The Bay Area-based pharma company Verseon began designing small-molecule drugs on a computational platform in 2002. That is well before most of the companies like Recursion and Exscientia now called AI drug discovery firms existed, and two decades before the launch of ChatGPT. Today, Verseon’s website states that its programs feature novel candidates that cannot…
The p...